Walele T - Search Results

1

Use of a rapid human primary cell-based disease screening model, to compare next generation products to combustible cigarettes.

Simms L, Mason E, Berg EL, Yu F, Rudd K, Czekala L, Trelles Sticken E, Brinster O, Wieczorek R, Stevenson M, Walele T. Simms L, et al. Among authors: walele t. Curr Res Toxicol. 2021 Aug 17;2:309-321. doi: 10.1016/j.crtox.2021.08.003. eCollection 2021. Curr Res Toxicol. 2021. PMID: 34485931 Free PMC article.

2

The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes.

Simms L, Rudd K, Palmer J, Czekala L, Yu F, Chapman F, Trelles Sticken E, Wieczorek R, Bode LM, Stevenson M, Walele T. Simms L, et al. Among authors: walele t. Curr Res Toxicol. 2020 Nov 15;1:161-173. doi: 10.1016/j.crtox.2020.11.001. eCollection 2020 Jun 10. Curr Res Toxicol. 2020. PMID: 34345845 Free PMC article.

3

Multi-endpoint analysis of human 3D airway epithelium following repeated exposure to whole electronic vapor product aerosol or cigarette smoke.

Czekala L, Wieczorek R, Simms L, Yu F, Budde J, Trelles Sticken E, Rudd K, Verron T, Brinster O, Stevenson M, Walele T. Czekala L, et al. Among authors: walele t. Curr Res Toxicol. 2021 Feb 20;2:99-115. doi: 10.1016/j.crtox.2021.02.004. eCollection 2021. Curr Res Toxicol. 2021. PMID: 34345855 Free PMC article.

4

A comparative in vitro toxicity assessment of electronic vaping product e-liquids and aerosols with tobacco cigarette smoke.

Wieczorek R, Phillips G, Czekala L, Trelles Sticken E, O'Connell G, Simms L, Rudd K, Stevenson M, Walele T. Wieczorek R, et al. Among authors: walele t. Toxicol In Vitro. 2020 Aug;66:104866. doi: 10.1016/j.tiv.2020.104866. Epub 2020 Apr 27. Toxicol In Vitro. 2020. PMID: 32353510 Free article.

5

The use of Genomic Allergen Rapid Detection (GARD) assays to predict the respiratory and skin sensitising potential of e-liquids.

Stevenson M, Czekala L, Simms L, Tschierske N, Larne O, Walele T. Stevenson M, et al. Among authors: walele t. Regul Toxicol Pharmacol. 2019 Apr;103:158-165. doi: 10.1016/j.yrtph.2019.01.001. Epub 2019 Jan 7. Regul Toxicol Pharmacol. 2019. PMID: 30629970 Free article.

6

Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model.

Czekala L, Simms L, Stevenson M, Tschierske N, Maione AG, Walele T. Czekala L, et al. Among authors: walele t. Regul Toxicol Pharmacol. 2019 Apr;103:314-324. doi: 10.1016/j.yrtph.2019.01.036. Epub 2019 Feb 2. Regul Toxicol Pharmacol. 2019. PMID: 30721718 Free article.

7

High Content Screening in NHBE cells shows significantly reduced biological activity of flavoured e-liquids, when compared to cigarette smoke condensate.

Czekala L, Simms L, Stevenson M, Trelles-Sticken E, Walker P, Walele T. Czekala L, et al. Among authors: walele t. Toxicol In Vitro. 2019 Aug;58:86-96. doi: 10.1016/j.tiv.2019.03.018. Epub 2019 Mar 14. Toxicol In Vitro. 2019. PMID: 30880017 Free article.

8

The in vitro ToxTracker and Aneugen Clastogen Evaluation extension assay as a tool in the assessment of relative genotoxic potential of e-liquids and their aerosols.

Czekala L, Chapman F, Simms L, Rudd K, Trelles Sticken E, Wieczorek R, Bode LM, Pani J, Moelijker N, Derr R, Brandsma I, Hendriks G, Stevenson M, Walele T. Czekala L, et al. Among authors: walele t. Mutagenesis. 2021 May 31;36(2):129-142. doi: 10.1093/mutage/geaa033. Mutagenesis. 2021. PMID: 33769537 Free PMC article.

9

Perception of the relative harm of electronic cigarettes compared to cigarettes amongst US adults from 2013 to 2016: analysis of the Population Assessment of Tobacco and Health (PATH) study data.

Malt L, Verron T, Cahours X, Guo M, Weaver S, Walele T, O'Connell G. Malt L, et al. Among authors: walele t. Harm Reduct J. 2020 Sep 18;17(1):65. doi: 10.1186/s12954-020-00410-2. Harm Reduct J. 2020. PMID: 32948187 Free PMC article.

10

A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers.

O'Connell G, Pritchard JD, Prue C, Thompson J, Verron T, Graff D, Walele T. O'Connell G, et al. Among authors: walele t. Intern Emerg Med. 2019 Sep;14(6):853-861. doi: 10.1007/s11739-019-02025-3. Epub 2019 Feb 2. Intern Emerg Med. 2019. PMID: 30712148 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page